Showing results (31-40 of 71) with videos related to
Sort By:
Pageof 8
Journal of the American College of Cardiology|February 19, 2013
Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery diseaseTorbjørn Omland, Marc A Pfeffer, Scott D Solomon, et al.European Heart Journal|October 26, 2012
Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studiesStuart J Pocock, Cono A Ariti, John J V McMurray, et al.Journal of the American College of Cardiology|February 21, 2006
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)John McMurray, Scott Solomon, Karen Pieper, et al.European Journal of Heart Failure|August 10, 2005
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practiceJohn McMurray, Alain Cohen-Solal, Rainer Dietz, et al.Journal of Cardiac Failure|June 8, 2013
Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptanPaul J Hauptman, John Burnett, Mihai Gheorghiade, et al.American Heart Journal|March 29, 2008
High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trialRachel E Anderson, Marc A Pfeffer, Jens Jakob Thune, et al.European Heart Journal|January 26, 2018
Big data from electronic health records for early and late translational cardiovascular research: challenges and potentialHarry Hemingway, Folkert W Asselbergs, John Danesh, et al.Heart Failure Reviews|September 21, 2011
A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trialMihai Gheorghiade, Peter S Pang, Andrew P Ambrosy, et al.American Heart Journal|February 8, 2020
Modeling defibrillation benefit for survival among cardiac resynchronization therapy defibrillator recipientsKenneth C Bilchick, Yongfei Wang, Jeptha P Curtis, et al.The American Journal of Cardiology|March 4, 2008
Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic functionJudith Hsia, Kathleen A Jablonski, Madeline Murguia Rice, et al.Pageof 8